Connect Biopharma Holdings Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Barry Quart
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 2yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
Connect Biopharma Holdings (NASDAQ:CNTB) Is In A Strong Position To Grow Its Business
Sep 27
Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth
Mar 07Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?
Sep 19Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?
Mar 29Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?
Dec 14Market Appears To Relegate Connect Biopharma To A Long-Term Hold
Oct 10Connect Biopharma Is A Sleeper Heading Into October Data Readout
Sep 26Connect Biopharma reports 1H results
Sep 13We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate
Aug 12We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate
Apr 29Connect Biopharma's Latest Dermatitis Drug Update Fails To Pump Up Shares
Jan 12We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely
Jan 01CEO
Barry Quart (67 yo)
less than a year
Tenure
Dr. Barry D. Quart, Pharm D., serves as Chief Executive Officer & Director of Connect Biopharma Holdings Limited since June 12, 2024. He had served as Chief Executive Officer of Heron Therapeutics, Inc. si...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Director | 12.8yrs | no data | 10.73% $ 5.9m | |
| Co-Founder & Director | no data | no data | 11.22% $ 6.2m | |
| CEO & Director | less than a year | no data | no data | |
| President | less than a year | no data | no data | |
| General Counsel & Chief Compliance Officer | 3.3yrs | no data | no data | |
| VP of Biologics & Head of CMC | 4.8yrs | no data | no data | |
| VP & Global Head of Medical Affairs | no data | no data | no data | |
| Senior Vice President of Clinical Development(Consultant) | less than a year | no data | no data |
2.0yrs
Average Tenure
60yo
Average Age
Experienced Management: CNTB's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Director | 12.8yrs | no data | 10.73% $ 5.9m | |
| Co-Founder & Director | 12.5yrs | no data | 11.22% $ 6.2m | |
| CEO & Director | less than a year | no data | no data | |
| Member of Scientific Advisory Board | 3.8yrs | no data | no data | |
| Independent Director | 3.3yrs | no data | 0% $ 0 | |
| Independent Non-Executive Director | 3.9yrs | no data | 0.018% $ 10.0k | |
| Independent Chairman | 3.9yrs | no data | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.8yrs | no data | no data | |
| Independent Non-Executive Director | 3.9yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.8yrs | no data | no data |
3.8yrs
Average Tenure
60.5yo
Average Age
Experienced Board: CNTB's board of directors are considered experienced (3.8 years average tenure).